Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Advanced Course on CAR-T and Next Generation Cell Therapies in Haematology and Solid Tumours 2021

Start date
25 Jun 2021
End date
26 Jun 2021
Virtual, CEST Time

Learning objectives

  • To learn the biological basis and mechanism of action of CAR-T and other engineered T cell therapy products
  • To learn the major clinical results and toxicities observed in CAR-T cell therapy trials and in the real-life use of CAR-T cells
  • To understand the major challenges related to the clinical use of CAR-T cells
  • To learn and discuss the most innovative T cell therapy approaches

Download the programme


The programme of this event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to  ESMO-MORA Recertification Process & Requirements.


  • Chiara Bonini, Italy
  • Fiona Thistlethwaite, United Kingdom

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.